Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function: A Prospective Randomised Controlled Trial.

Trial Profile

Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function: A Prospective Randomised Controlled Trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Ciclosporin (Primary)
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Acronyms CNIM-SRT
  • Most Recent Events

    • 07 Aug 2012 New source identified and integrated (European Clinical Trials Database record; EudraCT2007-002914-20).
    • 01 Dec 2009 Actual end date (1 Dec 2009) added as reported by ISRCTN: Current Controlled Trials.
    • 01 Dec 2009 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top